J&J has started its late-stage coronavirus vaccine trial

By Emilee Geist 3 years ago

Welcome to Business Insider‘s daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare

Welcome to Business Insider‘s daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.

<p class="copyright">Hollis Johnson/Business Insider</p>

Hollis Johnson/Business Insider

Hello,

Today in healthcare news: GoodRx is making its stock-market debut after pricing shares at $33 apiece just after midnight. At that price, the company is valued at $12.7 billion. What a time to be in the digital health/online prescription drug coupon business. 

Also: Johnson & Johnson has started a 60,000-person coronavirus vaccine trial, coronavirus deaths passed 200,000, and your ultimate guide to reading through vaccine data. 

Speaking of vaccines (and when are we not!):  Our biotech reporter Andrew Dunn is moderating a conversation on October 5 at 2 p.m. ET on the coronavirus vaccine race with 3 top experts:

  • Maria Elena Bottazzi, co-director of Texas Children’s Hospital Center for Vaccine Development

  • Art Caplan, bioethicist and founding head of the Division of Medical Ethics at New York University School of Medicine

  • Dr. William Haseltine, infectious-disease expert and chair and president of ACCESS Health International

Sign up here to attend!

<p class="copyright">Steve Parsons-WPA Pool/Getty Images</p>

Steve Parsons-WPA Pool/Getty Images

Pharma giant J&J just launched a pivotal 60,000-person coronavirus vaccine trial, and we could learn if the shot works by the end of 2020

  • Johnson & Johnson, the world’s largest healthcare company, advanced its coronavirus vaccine candidate into the final stage of clinical trials on Wednesday.

  • J&J will recruit up to 60,000 volunteers from around the world, including in the US, South Africa, Brazil, Argentina, Columbia, and Chile, said Paul Stoffels, the pharma giant’s chief scientific officer.

  • Dr. Anthony Fauci, the nation’s top infectious-disease expert, estimated that J&J’s trial will likely produce results in December or January.

Read the full story from Andrew Dunn here>>

Medical personnel move a deceased patient to a refrigerated truck serving as make shift morgues at Brooklyn Hospital Center on April 09, 2020 in New York City. - <p class="copyright">ANGELA WEISS/AFP via Getty Images</p>
Medical personnel move a deceased patient to a refrigerated truck serving as make shift morgues at Brooklyn Hospital Center on April 09, 2020 in New York City. –

ANGELA WEISS/AFP via Getty Images

The coronavirus has killed at least 200,000 people in the United States, another grim milestone for the pandemic

Read the full story from Yelena Dzhanova here>>

Deputy Director at the Vaccine Research Center at the National Institutes of Health, Dr. Barney Graham, speaks with President Donald Trump during a tour of the Viral Pathogenesis Laboratory at the National Institutes of Health, Tuesday, March 3, 2020, in Bethesda, Md. <p class="copyright">Evan Vucci/Associated Press</p>
Deputy Director at the Vaccine Research Center at the National Institutes of Health, Dr. Barney Graham, speaks with President Donald Trump during a tour of the Viral Pathogenesis Laboratory at the National Institutes of Health, Tuesday, March 3, 2020, in Bethesda, Md.

Evan Vucci/Associated Press

5 experts lay out how they’ll determine whether a coronavirus vaccine is really safe and effective — here’s what to know to evaluate the data for yourself

Read the full story from Andrew Dunn here>> 

More stories we’re reading:

Be sure to sign up for our newsletter here if you haven’t already!

– Lydia

Read the original article on Business Insider

Source Article

Tags: , , , ,